Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma

Title:	A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma
Authors:	Dasyam, Nathaniel^Aff1; Sharples, Katrina J.^{Aff2, Aff3}; Barrow, Catherine^Aff4; Huang, Ying^Aff3; Bauer, Evelyn^Aff1; Mester, Brigitta^Aff1; Wood, Catherine E.^{Aff1, Aff4}; Authier-Hall, Astrid^Aff1; Dzhelali, Marina^Aff4; Ostapowicz, Tess^Aff4; Kumar, Rajiv^Aff4; Lowe, Jessica^{Aff1, Aff4}; Maxwell, Alice^{Aff1, Aff4}; Burn, Olivia K.^Aff1; Williams, Geoffrey M.^{Aff5, Aff6}; Carley, Sarah E.^{Aff5, Aff6}; Caygill, Graham^Aff7; Jones, Jeremy^Aff7; Chan, Susanna T. S.^Aff8; Hinder, Victoria A.^Aff3; Macapagal, Jerome^Aff3; McCusker, Monica^Aff3; Weinkove, Robert^{Aff1, Aff4}; Brimble, Margaret A.^{Aff5, Aff6}; Painter, Gavin F.^Aff8; Findlay, Michael P.^Aff3; Dunbar, P. Rod^{Aff6, Aff9}; Gasser, Olivier^{Aff1, IDs0026202303400y_cor28}; Hermans, Ian F.^{Aff1, Aff6, IDs0026202303400y_cor29}
Source:	Cancer Immunology, Immunotherapy. 72(7):2267-2282
Database:	Springer Nature Journals